PALDINO, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 3.466
AS - Asia 2.941
EU - Europa 2.457
SA - Sud America 358
AF - Africa 107
OC - Oceania 9
Totale 9.338
Nazione #
US - Stati Uniti d'America 3.361
SG - Singapore 1.061
IT - Italia 796
CN - Cina 662
DE - Germania 326
VN - Vietnam 297
BR - Brasile 264
HK - Hong Kong 242
BD - Bangladesh 228
PL - Polonia 215
NL - Olanda 176
KR - Corea 175
SE - Svezia 164
FR - Francia 147
GB - Regno Unito 143
FI - Finlandia 133
RU - Federazione Russa 89
IN - India 70
CA - Canada 66
IE - Irlanda 56
BG - Bulgaria 47
CH - Svizzera 40
AR - Argentina 35
MA - Marocco 32
TR - Turchia 31
ES - Italia 27
ID - Indonesia 25
JP - Giappone 25
MX - Messico 24
ZA - Sudafrica 23
UA - Ucraina 21
EG - Egitto 19
IQ - Iraq 19
AT - Austria 18
CL - Cile 13
CO - Colombia 12
EC - Ecuador 12
PK - Pakistan 12
SA - Arabia Saudita 11
CZ - Repubblica Ceca 10
PH - Filippine 10
AE - Emirati Arabi Uniti 9
PY - Paraguay 9
IR - Iran 8
TW - Taiwan 8
AU - Australia 7
BE - Belgio 7
VE - Venezuela 7
KE - Kenya 6
GR - Grecia 5
KZ - Kazakistan 5
LT - Lituania 5
TH - Thailandia 5
JO - Giordania 4
LB - Libano 4
NP - Nepal 4
RO - Romania 4
RS - Serbia 4
SN - Senegal 4
UY - Uruguay 4
AL - Albania 3
AO - Angola 3
AZ - Azerbaigian 3
BY - Bielorussia 3
KG - Kirghizistan 3
LV - Lettonia 3
MY - Malesia 3
NG - Nigeria 3
NO - Norvegia 3
UZ - Uzbekistan 3
AM - Armenia 2
BO - Bolivia 2
BW - Botswana 2
BZ - Belize 2
CY - Cipro 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
GA - Gabon 2
IL - Israele 2
KW - Kuwait 2
PT - Portogallo 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
UG - Uganda 2
BB - Barbados 1
BF - Burkina Faso 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
GP - Guadalupe 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
KI - Kiribati 1
Totale 9.322
Città #
Singapore 631
Ashburn 516
San Jose 301
Hong Kong 220
Chandler 216
Dallas 182
Beijing 168
Trieste 162
Warsaw 162
Hefei 160
Seoul 160
Fairfield 142
Munich 138
Los Angeles 128
Council Bluffs 116
Chicago 112
Ho Chi Minh City 91
Milan 89
Helsinki 85
Seattle 84
Boardman 80
New York 68
Hanoi 64
London 62
Woodbridge 61
Santa Clara 60
Cambridge 58
Lauterbourg 55
Wilmington 53
Dublin 51
Amsterdam 48
Frankfurt am Main 47
Sofia 46
Zgierz 45
Princeton 42
Houston 39
Columbus 38
Buffalo 37
Moscow 34
Venice 29
Orem 28
Rome 28
Da Nang 27
Lappeenranta 27
São Paulo 27
Denver 25
Casablanca 24
Ann Arbor 23
Nuremberg 22
Bern 21
Redondo Beach 20
Naples 19
Brooklyn 18
San Diego 18
Florence 17
Memphis 17
Montreal 17
Bremen 16
Chennai 16
Toronto 16
Washington 16
Düsseldorf 15
Phoenix 15
Vienna 15
Boydton 14
Jacksonville 14
Salt Lake City 14
Shanghai 14
Tokyo 14
Turin 14
Turku 14
Elk Grove Village 13
Izmir 13
Münster 13
Stockholm 13
The Dalles 13
Atlanta 12
Dong Ket 12
Grafing 12
Berlin 11
Dearborn 11
Dhaka 11
Haiphong 11
Tampa 11
Boston 10
Charlotte 10
Giza 10
Paris 10
Bologna 9
Genoa 9
Redmond 9
San Francisco 9
Baghdad 8
Breda 8
Istanbul 8
Jeddah 8
Johannesburg 8
Poplar 8
Rio de Janeiro 8
Santiago 8
Totale 5.761
Nome #
High prevalence of subtle systolic and diastolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients 310
Galectin 3 and Galectin 3 Binding Protein Improve the Risk Stratification after Myocardial Infarction 292
Chapter 13: Current Management and Treatment 276
Cardiac Biomarkers in the Emergency Department: The Role of Soluble ST2 (sST2) in Acute Heart Failure and Acute Coronary Syndrome-There is Meat on the Bone 253
Genetics of Dilated Cardiomyopathy: Clinical Implications 247
Left bundle branch block in dilated cardiomyopathy with intermediate left ventricular dysfunction: clinical phenotyping and outcome correlates 246
TITIN DOWNREGULATION AFFECTS CARDIOMYOCYTES PROLIFERATION 243
Global longitudinal strain by CMR improves prognostic stratification in acute myocarditis presenting with normal LVEF 237
Arrhythmic risk stratification in patients with dilated cardiomyopathy and intermediate left ventricular dysfunction 230
Cardiac Magnetic Resonance Feature-Tracking Identifies Preclinical Abnormalities in Hypertrophic Cardiomyopathy Sarcomere Gene Mutation Carriers 224
ICD replacement in patients with intermediate left ventricular dysfunction under optimal medical treatment 222
Prevalence and evolution of right ventricular dysfunction among different genetic backgrounds in dilated cardiomyopathy 219
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric Study 219
Association of Titin Variations with Late-Onset Dilated Cardiomyopathy 214
Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy 199
Echocardiographic evaluation of centenarians in Trieste 195
Apoptosis, a useful marker in the management of hot-phase cardiomyopathy? 192
Hot Phases Cardiomyopathy: Pathophysiology, Diagnostic Challenges, and Emerging Therapies 192
Current diagnostic strategies for dilated cardiomyopathy: a comparison of imaging techniques 192
Impact of DCM-Causing Genetic Background on Long-Term Response to Cardiac Resynchronization Therapy 186
Strain analysis reveals subtle systolic dysfunction in confirmed and suspected myocarditis with normal LVEF. A cardiac magnetic resonance study 183
Phenotypic Expression, Natural History and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants 180
Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy 175
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants 170
Myocarditis: Which Role for Genetics? 170
Cardiomyopathies in children: Classification, diagnosis and treatment 168
Prognostic Prediction of Genotype vs Phenotype in Genetic Cardiomyopathies 163
Prognostic role of exercise intensity in familial Filamin C truncating variants 155
The response to cardiac resynchronization therapy in LMNA cardiomyopathy 154
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies 152
Critical analysis of the 2023 ESC guidelines on cardiomyopathy management 151
Cardiology of the future: xenotransplantation with porcine heart 146
Lymphocytic Myocarditis: A Genetically Predisposed Disease? 142
Prognostic value of echocardiographic evaluation of cardiac mechanics in patients with aortic stenosis and preserved left ventricular ejection fraction 139
SARS-CoV-2, myocardial injury and inflammation: insights from a large clinical and autopsy study 138
Focus on arrhythmogenic right ventricular cardiomyopathy 138
Whole-exome sequencing: Clinical characterization of pediatric and adult Italian patients affected by different forms of hereditary cardiovascular diseases 135
Toward standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial Function 132
Genetic testing in cardiomyopathies: updates and future perspectives 130
SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence 126
Generation of human induced pluripotent stem cell line EURACi015-A from a patient affected by dilated cardiomyopathy carrying the Lamin A/C p.Glu161Lys mutation 125
Subclinical systolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients: A systematic review and meta-analysis 125
Sport and Exercise in Genotype positive (+) Phenotype negative (-) Individuals. Current Dilemmas and Future Perspectives 124
Exercise Intensity and Cardiac Disease Development in carriers of Titin variants 120
Role of arrhythmic phenotype in prognostic stratification and management of dilated cardiomyopathy 118
Generation of iPSC lines (ICHi001-A, ICHi002-A, ICHi003-A, ICHi004-A) from four patients carrying Titin truncating variants associated with dilated cardiomyopathy 117
Fenotypic expressions and clinical manifestations of arrhythmogenic cardiomyopathy 116
New perspectives in diagnosis and risk stratification of non-ischaemic dilated cardiomyopathy 110
Mechanisms of myocardial reverse remodelling and its clinical significance: A scientific statement of the ESC Working Group on Myocardial Function 107
The contribution of cardiopulmonary exercise testing in the familial screening for dilated and non-dilated left ventricular cardiomyopathies: case series 99
Major arrhythmias in non-dilated left ventricular cardiomyopathy: a novel prediction score 93
Prediction and prognostic role of left ventricular systolic dysfunction in family screening for dilated cardiomyopathy and non-dilated left ventricular cardiomyopathy 92
Clustering in dilated cardiomyopathy at initial evaluation: An effective tool for clinical stratification 91
Titin-related familial dilated cardiomyopathy: factors associated with disease onset 73
Impact of genotype-phenotype associations on prognosis in dilated cardiomyopathy 70
Titin Cardiomyopathy, Emerging Evidence: More Than A Big Heart 69
Reply to the letter regarding the article 'Subclinical systolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients: A systematic review and meta-analysis' 65
Integrated role of cardiac magnetic resonance and genetics in predicting left ventricular reverse remodelling in dilated and non-dilated cardiomyopathy 60
Pregnancy in patients with inherited myocardial disorders – A consensus document on preconception counseling and pregnancy management by the working group on myocardial and pericardial disorders of the Italian Society of Cardiology 49
What Should a Clinical Cardiologist Know About Cardiogenetics? 34
Predictors of Disease Progression in Patients with Left Ventricular Non-Dilated Cardiomyopathy 29
Significance of common genetic variants associated with non-ischaemic cardiomyopathy in the general population 21
Twenty-Five-Year Follow-Up of the MDDC1 Family: A LMNA Gene Variant Associated With Dilated Cardiomyopathy With Variable Skeletal Muscle Involvement 21
Red Flags for Differentiating Desmosomal "Hot-Phase" Cardiomyopathy From Acute Myocarditis 20
External validation of the DSP-Risk Score for prediction of clinically significant ventricular arrhythmias in primary prevention patients with desmoplakin cardiomyopathy associated genetic variants 9
RBM20 Truncating Variants and Human Cardiomyopathy 8
Polygenic risk in early-onset coronary artery disease with low prevalence of traditional cardiovascular risk factors 6
Totale 9.606
Categoria #
all - tutte 27.319
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.319


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202129 0 0 0 0 0 0 0 0 0 0 0 29
2021/2022357 18 21 62 15 12 30 13 12 35 20 31 88
2022/2023572 39 80 55 86 63 92 4 46 50 10 37 10
2023/2024653 45 23 36 37 46 66 114 80 20 37 88 61
2024/20251.882 52 77 149 123 134 152 142 146 244 262 173 228
2025/20265.340 455 349 612 471 403 376 636 208 484 583 546 217
Totale 9.606